Seven Fleet Capital Management »

Athira Pharma shares owned by Seven Fleet Capital Management

Quarter-by-quarter ownership of Athira Pharma shares owned by Seven Fleet Capital Management from 13F filings

Historical chart of Seven Fleet Capital Management investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by Seven Fleet Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by Seven Fleet Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $969k 128k 7.57

More positions owned by Seven Fleet Capital Management

Cg Oncology (CGON)
Soleno Therapeutics (SLNO)
Revolution Medicines (RVMD)
Liquidia Corporation Com New (LQDA)
Compass Therapeutics (CMPX)
Exelixis (EXEL)
Axsome Therapeutics (AXSM)
Tyra Biosciences (TYRA)
Cogent Biosciences (COGT)
Tango Therapeutics (TNGX)
Xencor (XNCR)
Pharvaris N V (PHVS)
Terns Pharmaceuticals (TERN)
Belite Bio Sponsored Ads (BLTE)
Dyne Therapeutics (DYN)

View all positions for Seven Fleet Capital Management

Top funds holding Athira Pharma

Perceptive Advisors
TCG Crossover Management
Commodore Capital
ADAR1 Capital Management
Vanguard Group
Propel Bio Management
Simplify Asset Management
Seven Fleet Capital Management
Renaissance Technologies
Pathstone Holdings
BlackRock
Acadian Asset Management
Citadel Advisors
Geode Capital Management
Susquehanna International

View all funds holding Athira Pharma